Philips Healthcare is a part of Philips Electronics, and its employees are committed to compliance with our corporate General Business Principles or GBP. Learn more about our compliance programs.
As a health care company committed to providing innovative technology and services that enable health care providers to achieve clinical excellence, Philips Healthcare faces additional ethical and compliance challenges and obligations. So we have supplemented the GBP with a health care compliance program.
Philips Healthcare (Philips), a global leader in the growing medical device and diagnostic industry, is committed to providing innovative technology and services that enable health care providers to achieve clinical excellence.
Philips is also committed to strategically conducting business which is consistent with our mission, vision, and values. Philips compliance program is a vital component of a commitment to the highest standard of ethical corporate conduct.
Philips Healthcare, a division of Philips Electronics North America Corp., and its affiliates (“Philips”), has established and is operating under a Comprehensive Compliance Program (“CCP”).
Where applicable, is in accordance with the “Compliance Program Guidance for Pharmaceutical Manufacturers” issued by the United States Department of Health and Human Services Office of Inspector General (“CPG”), and the AdvaMed and NEMA/MITA Codes of Ethics on Interactions with Healthcare Providers (“Device Industry Codes”).
Not a drug manufacturer
Because Philips is a medical device manufacturer – not a drug manufacturer – certain guidance set forth in the CPG does not apply to Philips and its operations. Similarly, Philips’ CCP is based on Device Industry Codes and not the PhRMA Code of Ethics for the pharmaceutical industry.
With these clarifications and Philips’ good faith understanding of the statutory requirements, Philips is – to the best of its knowledge – in compliance with the provisions of the California Health and Safety Code §§119400-119402, to the extent they apply to Philips Healthcare.
[Updated 03-04-2014]
Compliance updates
Please note that our Philips Healthcare compliance program may vary from country to country to reflect legal differences, and not all programs are available for posting.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.
What's trending
News
Philips aims to advance cardiac MRI technology through AI-driven research
Click to read morePhilips strengthens strategic partnership with Sim&Cure to expand innovation in neurovascular therapy
Click to read morePhilips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology
Click to read more